What is the ICD (International Classification of Diseases) code for pseudofolliculitis barbae (ingrown hair)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

The ICD-10 code for ingrown hair is L73.0, which is classified under "Other follicular disorders". This code specifically represents pseudofolliculitis barbae, the medical term for ingrown hairs. Ingrown hairs occur when hair curls back or grows sideways into the skin, causing inflammation, redness, and sometimes infection. This condition commonly affects areas where hair is removed through shaving, waxing, or plucking, such as the face, neck, legs, or pubic area. When documenting this condition in medical records, healthcare providers should note the location, severity, and any associated symptoms like pustules or hyperpigmentation.

Key Considerations

  • The condition is more prevalent in individuals with curly hair, particularly those of African descent 1.
  • Treatment typically involves proper shaving techniques, exfoliation, topical retinoids like tretinoin, or antibiotics if infection is present 2, 3.
  • In severe cases, procedures like laser hair removal might be recommended, which has been shown to be safe and effective in most skin types 3.
  • The code L73.0 helps ensure accurate medical billing and appropriate treatment planning for patients suffering from this common dermatological condition.

Recent Evidence

A recent review of treatments for pseudofolliculitis barbae published in 2023 1 highlights the importance of a multifaceted approach to treatment, including preventive measures, antibiotics, corticosteroids, keratolytics, chemical depilatories, and/or laser treatments. Topical therapies are currently the mainstay treatment, but laser hair removal has become a potential long-term treatment option.

Clinical Implications

Healthcare providers should be aware of the latest treatment options and recommendations for pseudofolliculitis barbae, particularly in patients with skin of color, to address the prominent disparity in healthcare management and improve the quality of care for these patients 1.

References

Research

Review of treatments for pseudofolliculitis barbae.

Clinical and experimental dermatology, 2023

Research

[Pseudofolliculitis barbae].

Actas dermo-sifiliograficas, 2010

Research

Pseudofolliculitis cutis: a vexing disorder of hair growth.

The British journal of dermatology, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.